Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Sarre

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
BMC Health Services Research|February 17, 2024
The complexity of leadership in coproduction practices: a guiding framework based on a systematic literature reviewSofia Kjellström, Sophie Sarre, Daniel Masterson
Rapid Communications in Mass Spectrometry : RCM|March 1, 2007
Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometryKatrien Lanckmans, Sophie Sarre, Ilse Smolders, et al.
Talanta|March 29, 2008
Quantitative liquid chromatography/mass spectrometry for the analysis of microdialysatesKatrien Lanckmans, Sophie Sarre, Ilse Smolders, et al.
Brain Research|January 30, 2002
MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson ratsNadine Jonkers, Sophie Sarre, Guy Ebinger, et al.
The European Journal of Neuroscience|September 23, 2011
The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell deathBirgit Mertens, Mustafa Varcin, Yvette Michotte, et al.
Neuropharmacology|January 26, 2010
Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatumBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
Oxidative Medicine and Cellular Longevity|July 26, 2012
Oxidative stress in genetic mouse models of Parkinson's diseaseMustafa Varçin, Eduard Bentea, Yvette Michotte, et al.
Brain Research|October 13, 2004
Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's diseaseHong Yuan, Sophie Sarre, Guy Ebinger, et al.
Journal of Neuroscience Methods|April 26, 2005
Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's diseaseHong Yuan, Sophie Sarre, Guy Ebinger, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 29, 2009
The role of the central renin-angiotensin system in Parkinson's diseaseBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
BMC Health Services Research|February 17, 2024
The complexity of leadership in coproduction practices: a guiding framework based on a systematic literature reviewSofia Kjellström, Sophie Sarre, Daniel Masterson
Rapid Communications in Mass Spectrometry : RCM|March 1, 2007
Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometryKatrien Lanckmans, Sophie Sarre, Ilse Smolders, et al.
Talanta|March 29, 2008
Quantitative liquid chromatography/mass spectrometry for the analysis of microdialysatesKatrien Lanckmans, Sophie Sarre, Ilse Smolders, et al.
Brain Research|January 30, 2002
MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson ratsNadine Jonkers, Sophie Sarre, Guy Ebinger, et al.
The European Journal of Neuroscience|September 23, 2011
The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell deathBirgit Mertens, Mustafa Varcin, Yvette Michotte, et al.
Neuropharmacology|January 26, 2010
Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatumBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
Oxidative Medicine and Cellular Longevity|July 26, 2012
Oxidative stress in genetic mouse models of Parkinson's diseaseMustafa Varçin, Eduard Bentea, Yvette Michotte, et al.
Brain Research|October 13, 2004
Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's diseaseHong Yuan, Sophie Sarre, Guy Ebinger, et al.
Journal of Neuroscience Methods|April 26, 2005
Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's diseaseHong Yuan, Sophie Sarre, Guy Ebinger, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 29, 2009
The role of the central renin-angiotensin system in Parkinson's diseaseBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
Pageof 6